Erdheim-Chester Disease Market Insights: Emerging Therapies and Business Opportunities
Erdheim-Chester Disease (ECD) is a rare, non-Langerhans cell histiocytosis marked by the abnormal buildup of histiocytes in bone and soft tissue. Because it affects only a small number of patients worldwide, the disease has long been under-researched, but growing awareness among clinicians and a wave of new therapeutic candidates are reshaping how the condition is…
